Raymond James & Associates’s PLx Pharma Inc. Common Stock PLXP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-66,558
| Closed | -$533K | – | 4106 |
|
|
2021
Q4 | $533K | Sell |
66,558
-30,061
| -31% | -$241K | ﹤0.01% | 3023 |
|
|
2021
Q3 | $1.87M | Buy |
96,619
+6,089
| +7% | +$118K | ﹤0.01% | 2154 |
|
|
2021
Q2 | $1.25M | Sell |
90,530
-11,183
| -11% | -$154K | ﹤0.01% | 2436 |
|
|
2021
Q1 | $918K | Buy |
+101,713
| New | +$918K | ﹤0.01% | 2565 |
|
|
2018
Q3 | – | Sell |
-10,448
| Closed | -$41K | – | 3584 |
|
|
2018
Q2 | $41K | Sell |
10,448
-1,682
| -14% | -$6.6K | ﹤0.01% | 3404 |
|
|
2018
Q1 | $41K | Buy |
12,130
+500
| +4% | +$1.69K | ﹤0.01% | 3293 |
|
|
2017
Q4 | $80K | Buy |
+11,630
| New | +$80K | ﹤0.01% | 3190 |
|
|
2016
Q4 | – | Sell |
-7,587
| Closed | -$880K | – | 3199 |
|
|
2016
Q3 | $880K | Buy |
7,587
+3,658
| +93% | +$424K | ﹤0.01% | 1959 |
|
|
2016
Q2 | $312K | Buy |
+3,929
| New | +$312K | ﹤0.01% | 2388 |
|